You are here:
Abbott Laboratories
#

Abbott Laboratories

Get Alerts

Articles

View all

Govt panel proposes to regulate prices of patented drugs

Feb 27, 2013

Govt panel proposes to regulate prices of patented drugs

A panel formed under the ministry of chemicals and fertilizers has recommended setting up a committee to negotiate with drugmakers to fix prices of costly drugs used to treat deadly diseases such as cancer, HIV and hepatitis. #Cipla #PolicyWatch #Pharma #Abbott Laboratories #Drugmakers
The 11% solution: Why Piramal has taken a bigger bite of Vodafone

Feb 08, 2012

The 11% solution: Why Piramal has taken a bigger bite of Vodafone

Ajay Piramal, who made a healthy exit from Abbott and reaped loads of cash, has now bought a bigger share of Vodafone. Here's his gameplan #Ajay Piramal #Vodafone #Piramal Healthcare #Smartcompany #Sudhir Dash #Abbott Laboratories

Wire

View all

The 11% solution: Why Piramal has taken a bigger bite of Vodafone

Jul 14, 2014

Abbott to sell portion of generic drug business for $5.3 billion

Abbott Laboratories has agreed to sell its branded generic drug business in developed countries to Mylan Inc. in a deal valued at $5.3 billion...
The 11% solution: Why Piramal has taken a bigger bite of Vodafone

Jun 24, 2014

U.S. firm Abbott to buy Russian drugmaker for up to $495 mln

U.S. healthcare firm Abbott Laboratories is to buy Russian drugmaker Veropharm for up to $495 million, giving it a manufacturing presence in a country where it has been operating for nearly 40 years, Abbott said on Tuesday...
The 11% solution: Why Piramal has taken a bigger bite of Vodafone

Jul 14, 2014

Drugmakers AbbVie, Shire in merger talks

Drugmakers AbbVie and Shire have entered detailed talks about a possible combination after AbbVie raised its bid once again and offered to give Shire shareholders a bigger stake in the resulting company. Shire said Monday that North Chicago, Illinois... #Chicago, IL #Illinois #Shire P.L.C. #European Union #Abbott Laboratories